{"schema":"hottub-news/prospects/v1","item":{"id":"n_mu66pxyte2er5myyscbq","title":"Ichnos Glenmark Innovation Inc.: Ichnos Glenmark Innovation (IGI) Announces IND Submission to U.S. FDA for ISB 2301, a First-in-Class Multispecific Immune Cell Activator Targeting Solid Tumors","title_en":null,"url":"https://www.finanznachrichten.de/nachrichten-2026-11/70157817-ichnos-glenmark-innovation-inc-ichnos-glenmark-innovation-igi-announces-ind-submission-to-u-s-fda-for-isb-2301-a-first-in-class-multispecific-im-008.htm","outlet":"Finanznachrichten.de","published":"2026-11-17T18:36:00Z","sponsored":false,"page":"https://hottub.news/articles/n_mu66pxyte2er5myyscbq"},"prospects":[{"name":"United States Food and Drug Administration","kind":"organization","role":"named","entity":"wikidata:Q204711","source":"https://www.finanznachrichten.de/nachrichten-2026-11/70157817-ichnos-glenmark-innovation-inc-ichnos-glenmark-innovation-igi-announces-ind-submission-to-u-s-fda-for-isb-2301-a-first-in-class-multispecific-im-008.htm","note":"In the news: Ichnos Glenmark Innovation Inc.: Ichnos Glenmark Innovation (IGI) Announces IND Submission to U.S. FDA for ISB 2301, a First-in-Class Multispecific Immune Cell Activator Targeting Solid Tumors (Finanznachrichten.de, 2026-11-17)","reason":"Named in a headline on 2026-11-17: “Ichnos Glenmark Innovation Inc.: Ichnos Glenmark Innovation (IGI) Announces IND Submission to U.S. FDA for ISB 2301, a First-in-Class Multispecific Immune Cell Activator Targeting Solid Tumors” (Finanznachrichten.de)","group":"Organizations","add_url":"https://crm.joinhottub.com/relationships/add#name=United%20States%20Food%20and%20Drug%20Administration&kind=organization&source=https%3A%2F%2Fwww.finanznachrichten.de%2Fnachrichten-2026-11%2F70157817-ichnos-glenmark-innovation-inc-ichnos-glenmark-innovation-igi-announces-ind-submission-to-u-s-fda-for-isb-2301-a-first-in-class-multispecific-im-008.htm&entity=wikidata%3AQ204711&note=In%20the%20news%3A%20Ichnos%20Glenmark%20Innovation%20Inc.%3A%20Ichnos%20Glenmark%20Innovation%20%28IGI%29%20Announces%20IND%20Submission%20to%20U.S.%20FDA%20for%20ISB%202301%2C%20a%20First-in-Class%20Multispecific%20Immune%20Cell%20Activator%20Targeting%20Solid%20Tumors%20%28Finanznachrichten.de%2C%202026-11-17%29","propose":{"name":"United States Food and Drug Administration","kind":"organization","reason":"Named in a headline on 2026-11-17: “Ichnos Glenmark Innovation Inc.: Ichnos Glenmark Innovation (IGI) Announces IND Submission to U.S. FDA for ISB 2301, a First-in-Class Multispecific Immune Cell Activator Targeting Solid Tumors” (Finanznachrichten.de)","requestId":"news:n_mu66pxyte2er5myyscbq:wikidata:Q204711:6bc4a384","sourceUrl":"https://www.finanznachrichten.de/nachrichten-2026-11/70157817-ichnos-glenmark-innovation-inc-ichnos-glenmark-innovation-igi-announces-ind-submission-to-u-s-fda-for-isb-2301-a-first-in-class-multispecific-im-008.htm","entity":"wikidata:Q204711"}},{"name":"PR Newswire","kind":"person","role":"reporter","company":"Finanznachrichten.de","website":"https://finanznachrichten.de/","source":"https://www.finanznachrichten.de/nachrichten-2026-11/70157817-ichnos-glenmark-innovation-inc-ichnos-glenmark-innovation-igi-announces-ind-submission-to-u-s-fda-for-isb-2301-a-first-in-class-multispecific-im-008.htm","note":"Wrote: Ichnos Glenmark Innovation Inc.: Ichnos Glenmark Innovation (IGI) Announces IND Submission to U.S. FDA for ISB 2301, a First-in-Class Multispecific Immune Cell Activator Targeting Solid Tumors","reason":"Reporter at Finanznachrichten.de; wrote “Ichnos Glenmark Innovation Inc.: Ichnos Glenmark Innovation (IGI) Announces IND Submission to U.S. FDA for ISB 2301, a First-in-Class Multispecific Immune Cell Activator Targeting Solid Tumors” on 2026-11-17","group":"Reporters","add_url":"https://crm.joinhottub.com/relationships/add#name=PR%20Newswire&company=Finanznachrichten.de&website=https%3A%2F%2Ffinanznachrichten.de%2F&source=https%3A%2F%2Fwww.finanznachrichten.de%2Fnachrichten-2026-11%2F70157817-ichnos-glenmark-innovation-inc-ichnos-glenmark-innovation-igi-announces-ind-submission-to-u-s-fda-for-isb-2301-a-first-in-class-multispecific-im-008.htm&note=Wrote%3A%20Ichnos%20Glenmark%20Innovation%20Inc.%3A%20Ichnos%20Glenmark%20Innovation%20%28IGI%29%20Announces%20IND%20Submission%20to%20U.S.%20FDA%20for%20ISB%202301%2C%20a%20First-in-Class%20Multispecific%20Immune%20Cell%20Activator%20Targeting%20Solid%20Tumors","propose":{"name":"PR Newswire","kind":"person","reason":"Reporter at Finanznachrichten.de; wrote “Ichnos Glenmark Innovation Inc.: Ichnos Glenmark Innovation (IGI) Announces IND Submission to U.S. FDA for ISB 2301, a First-in-Class Multispecific Immune Cell Activator Targeting Solid Tumors” on 2026-11-17","requestId":"news:n_mu66pxyte2er5myyscbq:Reporter:60fefb53:6f5ac79e","company":"Finanznachrichten.de","website":"https://finanznachrichten.de/","sourceUrl":"https://www.finanznachrichten.de/nachrichten-2026-11/70157817-ichnos-glenmark-innovation-inc-ichnos-glenmark-innovation-igi-announces-ind-submission-to-u-s-fda-for-isb-2301-a-first-in-class-multispecific-im-008.htm"}},{"name":"Finanznachrichten.de","kind":"organization","role":"outlet","website":"https://finanznachrichten.de/","entity":"wikidata:Q1408247","source":"https://www.finanznachrichten.de/nachrichten-2026-11/70157817-ichnos-glenmark-innovation-inc-ichnos-glenmark-innovation-igi-announces-ind-submission-to-u-s-fda-for-isb-2301-a-first-in-class-multispecific-im-008.htm","note":"Published: Ichnos Glenmark Innovation Inc.: Ichnos Glenmark Innovation (IGI) Announces IND Submission to U.S. FDA for ISB 2301, a First-in-Class Multispecific Immune Cell Activator Targeting Solid Tumors (2026-11-17)","reason":"Published “Ichnos Glenmark Innovation Inc.: Ichnos Glenmark Innovation (IGI) Announces IND Submission to U.S. FDA for ISB 2301, a First-in-Class Multispecific Immune Cell Activator Targeting Solid Tumors” on 2026-11-17","group":"Outlet","add_url":"https://crm.joinhottub.com/relationships/add#name=Finanznachrichten.de&kind=organization&website=https%3A%2F%2Ffinanznachrichten.de%2F&source=https%3A%2F%2Fwww.finanznachrichten.de%2Fnachrichten-2026-11%2F70157817-ichnos-glenmark-innovation-inc-ichnos-glenmark-innovation-igi-announces-ind-submission-to-u-s-fda-for-isb-2301-a-first-in-class-multispecific-im-008.htm&entity=wikidata%3AQ1408247&note=Published%3A%20Ichnos%20Glenmark%20Innovation%20Inc.%3A%20Ichnos%20Glenmark%20Innovation%20%28IGI%29%20Announces%20IND%20Submission%20to%20U.S.%20FDA%20for%20ISB%202301%2C%20a%20First-in-Class%20Multispecific%20Immune%20Cell%20Activator%20Targeting%20Solid%20Tumors%20%282026-11-17%29","propose":{"name":"Finanznachrichten.de","kind":"organization","reason":"Published “Ichnos Glenmark Innovation Inc.: Ichnos Glenmark Innovation (IGI) Announces IND Submission to U.S. FDA for ISB 2301, a First-in-Class Multispecific Immune Cell Activator Targeting Solid Tumors” on 2026-11-17","requestId":"news:n_mu66pxyte2er5myyscbq:wikidata:Q1408247:fc693afe","website":"https://finanznachrichten.de/","sourceUrl":"https://www.finanznachrichten.de/nachrichten-2026-11/70157817-ichnos-glenmark-innovation-inc-ichnos-glenmark-innovation-igi-announces-ind-submission-to-u-s-fda-for-isb-2301-a-first-in-class-multispecific-im-008.htm","entity":"wikidata:Q1408247"}}],"someone_else":{"source":"https://www.finanznachrichten.de/nachrichten-2026-11/70157817-ichnos-glenmark-innovation-inc-ichnos-glenmark-innovation-igi-announces-ind-submission-to-u-s-fda-for-isb-2301-a-first-in-class-multispecific-im-008.htm","note":"In the news: Ichnos Glenmark Innovation Inc.: Ichnos Glenmark Innovation (IGI) Announces IND Submission to U.S. FDA for ISB 2301, a First-in-Class Multispecific Immune Cell Activator Targeting Solid Tumors (Finanznachrichten.de, 2026-11-17)"},"crm":{"name":"CRM by Hottub","add":"Open add_url in a browser: CRM by Hottub's add form, filled in. Nothing is saved until the person presses Add.","mcp":"https://crm.joinhottub.com/api/crm/mcp","tool":"propose_relationship","propose":"If you're connected to CRM by Hottub's MCP server with proposal access, call propose_relationship with `propose` as its arguments. An owner approves it before anything is added. Keep the arguments as given: retries reuse requestId."}}